We did not find any difference of differential expression of the other immune target genes (e.g., LAG3, CTLA4, or HAVCR2) in BCC compared to healthy skin tissue in the presence or absence of high As exposure that could suggest the potential use of other immune checkpoint inhibitors targeting those genes. Here, CTLA4 is linked to skin basal cell carcinoma.